{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:51:19Z","timestamp":1778802679447,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009898","name":"Defense Health Agency","doi-asserted-by":"publisher","award":["IHB-16-08"],"award-info":[{"award-number":["IHB-16-08"]}],"id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10900-017-0447-z","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T05:56:57Z","timestamp":1511330217000},"page":"441-447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-1372","authenticated-orcid":false,"given":"Christopher M.","family":"Daly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul O.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"447_CR1","volume-title":"Human papillomaviruses. Principles and practice of pediatric infectious diseases","author":"L Hwang","year":"2012","unstructured":"Hwang, L., & Moscicki, A. B. (2012). Human papillomaviruses. Principles and practice of pediatric infectious diseases. Edinburgh: Elsevier\/Saunders."},{"issue":"3","key":"447_CR2","first-page":"1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski, K. A., & Bolan, G. A. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64(3), 1\u2013137.","journal-title":"MMWR Recommendations and Reports"},{"issue":"9","key":"447_CR3","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1086\/507909","volume":"194","author":"CM Wheeler","year":"2006","unstructured":"Wheeler, C. M., Hunt, W. C., Schiffman, M., & Castle, P. E. (2006). Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. The Journal of Infectious Diseases, 194(9), 1291\u20131299.","journal-title":"The Journal of Infectious Diseases"},{"key":"447_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.vaccine.2006.06.018","volume":"24","author":"AB Moscicki","year":"2006","unstructured":"Moscicki, A. B., Schiffman, M., Kjaer, S., & Villa, L. L. (2006). Updating the natural history of HPV and anogenital cancer. Vaccine, 24, 42\u201351.","journal-title":"Vaccine"},{"key":"447_CR5","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., et al. (2012). Global burden of human papillomavirus and related diseases. Vaccine, 30, F12\u2013F23.","journal-title":"Vaccine"},{"issue":"4","key":"447_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55(4), 244\u2013265.","journal-title":"Journal of Clinical Pathology"},{"key":"447_CR7","unstructured":"U.S. Department of Health and Human Services. (2014). Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. A report to the President of the United States from The President\u2019s Cancer Panel. Bethesda, MD: National Cancer Institute. \n                    http:\/\/deainfo.nci.nih.gov\/advisory\/pcp\/annualReports\/HPV\/PDF\/PCP_Annual_Report_2012-2013.pdf\n                    \n                  ."},{"key":"447_CR8","unstructured":"American Cancer Society. (2013). Cancer facts and figures. \n                    https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2013.html\n                    \n                  ."},{"issue":"5","key":"447_CR9","first-page":"1","volume":"63","author":"LE Markowitz","year":"2014","unstructured":"Markowitz, L. E., Dunne, E. E., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J., Bocchini, J. A., et al. (2014). Human papillomavirus vaccination recommendations of the advisory committee on immunization practices. MMWR Recommendations and Reports, 63(5), 1\u201330.","journal-title":"MMWR Recommendations and Reports"},{"issue":"3","key":"447_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","volume":"40","author":"CL Satterwhite","year":"2013","unstructured":"Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Du, J., et al. (2013). Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sexually Transmitted Diseases, 40(3), 187\u2013193.","journal-title":"Sexually Transmitted Diseases"},{"issue":"3","key":"447_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/aje\/kwf180","volume":"157","author":"RL Winer","year":"2003","unstructured":"Winer, R. L. (2003). Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. American Journal of Epidemiology, 157(3), 218\u2013226.","journal-title":"American Journal of Epidemiology"},{"issue":"7","key":"447_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GYF Ho","year":"1998","unstructured":"Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine, 338(7), 423\u2013428.","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"447_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/00006454-199807000-00014","volume":"17","author":"AB Moscicki","year":"1998","unstructured":"Moscicki, A. B. (1998). Genital infections with human papillomavirus (HPV). The Pediatric Infectious Disease Journal, 17(7), 651\u2013652.","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"5","key":"447_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1086\/315086","volume":"180","author":"EL Franco","year":"1999","unstructured":"Franco, E. L., Villa, L. L., Sobrinho, J. P., Prado, J. M., Rousseau, M. C., Desy, M., & Rohan, T. E. (1999). Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. Journal of Infectious Diseases, 180(5), 1415\u20131423.","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"447_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/aje\/kwg171","volume":"158","author":"M Molano","year":"2003","unstructured":"Molano, M., van den Brule, A., Plummer, M., Weiderpass, E., Posso, H., Arslan, A., Meijer, C. J. L. M., et al. (2003). Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: A population-based, 5-year follow-up study. American Journal of Epidemiology, 158(5), 486\u2013494.","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"447_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/infdis\/jir342","volume":"204","author":"EF Dunne","year":"2011","unstructured":"Dunne, E. F., Sternberg, M., Markowitz, L. E., McQuillan, G., Swan, D., Patel, S., & Unger, E. R. (2011). Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States-National Health and Nutrition Examination Survey, 2003\u20132006: Opportunity to measure HPV vaccine impact? Journal of Infectious Diseases, 204(4), 562\u2013565.","journal-title":"Journal of Infectious Diseases"},{"key":"447_CR17","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","volume":"30","author":"AB Moscicki","year":"2012","unstructured":"Moscicki, A. B., Schiffman, M., Burchell, A., Albero, G., Giuliano, A. R., Goodman, M. T., Kjaer, S. K., et al. (2012). Updating the natural history of human papillomavirus and anogenital cancers. Vaccine, 30, F24\u2013F33.","journal-title":"Vaccine"},{"issue":"9769","key":"447_CR18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","volume":"377","author":"AR Giuliano","year":"2011","unstructured":"Giuliano, A. R., Lee, J. H., & Fulp, W. (2011). Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet, 377(9769), 932\u2013940.","journal-title":"Lancet"},{"issue":"2","key":"447_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/infdis\/169.2.235","volume":"169","author":"A Hildesheim","year":"1994","unstructured":"Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., et al. (1994). Persistence of type-specific human papillomavirus infection among cytologically normal women. Journal of Infectious Diseases, 169(2), 235\u2013240.","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"447_CR20","first-page":"21","volume":"20","author":"BK Agan","year":"2013","unstructured":"Agan, B. K., Macalino, G. E., Nsouli-Maktabi, H., Wang, X., Gaydos, J. C., Ganesan, A., & Sanchez, J. L. (2013). Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service. MSMR, 20(2), 21\u201324.","journal-title":"MSMR"},{"issue":"2","key":"447_CR21","first-page":"17","volume":"20","author":"H Nsouli-Maktabi","year":"2013","unstructured":"Nsouli-Maktabi, H., Ludwig, S. L., Yerubandi, U. D., & Gaydos, J. C. (2013). Incidence of genital warts among U.S. servicemembers before and after the introduction of the quadrivalent human papillomavirus vaccine. MSMR, 20(2), 17\u201320.","journal-title":"MSMR"},{"issue":"5","key":"447_CR22","first-page":"16","volume":"19","author":"H Maktabi","year":"2012","unstructured":"Maktabi, H., Ludwig, S. L., Eick-Cost, A., Yerubandi, U. D., & Gaydos, J. C. (2012). Quadrivalent human papillomavirus vaccine initiation, coverage, and compliance among U.S. active component service women, 2006\u20132011. MSMR, 19(5), 16.","journal-title":"MSMR"},{"issue":"42","key":"447_CR23","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","volume":"30","author":"HW Chesson","year":"2012","unstructured":"Chesson, H. W., Ekwueme, D. U., Saraiya, M., Watson, M., Lowy, D. R., & Markowitz, L. E. (2012). Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine, 30(42), 6016\u20136019.","journal-title":"Vaccine"},{"issue":"8","key":"447_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura, E. A., Giuliano, A. R., Iversen, O. E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., et al. (2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in Women. New England Journal of Medicine, 372(8), 711\u2013723.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"447_CR25","doi-asserted-by":"publisher","first-page":"E1148-E1156","DOI":"10.1542\/peds.2014-2101","volume":"135","author":"AC Dunn","year":"2015","unstructured":"Dunn, A. C., Black, C. L., Arnold, J., Brodine, S., Waalen, J., & Binkin, N. (2015). Childhood vaccination coverage rates among military dependents in the United States. Pediatrics, 135(5), E1148-E1156.","journal-title":"Pediatrics"},{"issue":"11","key":"447_CR26","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1128\/JCM.05552-11","volume":"49","author":"DAM Heideman","year":"2011","unstructured":"Heideman, D. A. M., Hesselink, A. T., Berkhof, J., van Kemenade, F., Melchers, W. J. G., Daalmeijer, N. F., Verkuijten, M., et al. (2011). Clinical validation of the cobas 4800 HPV test for cervical screening purposes. Journal of Clinical Microbiology, 49(11), 3983\u20133985.","journal-title":"Journal of Clinical Microbiology"},{"issue":"3","key":"447_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/infdis\/jit192","volume":"208","author":"LE Markowitz","year":"2013","unstructured":"Markowitz, L. E., Hariri, S., Lin, C., Dunne, E. F., Steinau, M., McQuillan, G., & Unger, E. R. (2013). Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003\u20132010. Journal of Infectious Diseases, 208(3), 385\u2013393.","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"447_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2015-1968","volume":"137","author":"LE Markowitz","year":"2016","unstructured":"Markowitz, L. E., Liu, G., Hariri, S., Steinau, M., Dunne, E. F., & Unger, E. R. (2016). Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics, 137(3), 1\u20139.","journal-title":"Pediatrics"},{"issue":"6","key":"447_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv086","volume":"107","author":"M Saraiya","year":"2015","unstructured":"Saraiya, M., Unger, E. R., Thompson, T. D., Lynch, C. F., Hernandez, B. Y., Lyu, C. W., Steinau, M., et al. (2015). US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute, 107(6), 1\u201312.","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"447_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0048807","volume":"7","author":"M Scherpenisse","year":"2012","unstructured":"Scherpenisse, M., Mollers, M., Schepp, R. M., Boot, H. J., Meijer, C. J. L. M., Berbers, G. A. M., van der Klis, F. R. M., et al. (2012). Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995 to 96 and 2006\u201307 in The Netherlands. PLoS ONE, 7(11), 1\u20138.","journal-title":"PLoS ONE"}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10900-017-0447-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-017-0447-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-017-0447-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T10:14:24Z","timestamp":1589710464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10900-017-0447-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1007\/s10900-017-0447-z","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"value":"0094-5145","type":"print"},{"value":"1573-3610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,22]]},"assertion":[{"value":"22 November 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}